Serum levels of KL-6 are positively correlated with those of CA15-3 in patients with interstitial pneumonia associated with collagen diseases [1]

Respirology

Volumn 11, Issue 4, 2006, Pages 509-510

  Okada, Makoto ^a   Suzuki, Kimihiro ^a   Nakanishi, Takashi ^a   Nakashima, Masahiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 15-3 ANTIGEN; GLYCOPROTEIN; MUCIN 1; PROTEIN KL 6; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLLAGEN DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMATOMYOSITIS; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LETTER; MAMMOGRAPHY; MIXED CONNECTIVE TISSUE DISEASE; NORMAL VALUE; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SERUM; SYSTEMIC SCLEROSIS;

ANTIGENS, NEOPLASM; CA-15-3 ANTIGEN; COLLAGEN DISEASES; HUMANS; LUNG DISEASES, INTERSTITIAL; MUCINS;

EID: 33744720688     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.00881.x     Document Type: Letter

References (10)

1. Wong RC Klingberg S Wilson R. CA15-3 and cancer associated serum antigen assays are alternatives to the KL-6 assay for measuring serum MUC-1 levels in patients with interstitial lung disease associated with polymyositis/ dermatomyositis. J. Rheumatol. 2002 29 : 2021 2.
2. Kohno N. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J. Med. Invest. 1999 46 : 151 8.
3. Kobayashi J Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest 1995 108 : 311 15.
4. Kallioniemi OP Oksa H Aaran RK Hietanen T Lehtinen M Koivula T. Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer. Br. J. Cancer 1988 58 : 213 15.
5. Hilkens J Buijs F Hilgers J et al. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int. J. Cancer 1984 34 : 197 206.
6. Kufe D Inghirami G Abe M Hayes D Justi-Wheeler H Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984 3 : 223 32.
7. Matsui A Ikeda T Masamura S Kitajima M. CA15-3. Nippon Rinsho 1999 Suppl. 57 474 7.
8. Baldus SE Engelmann K Hanisch FG. MUC1 and the MUCs: a family of human mucins with impact in cancer biology. Crit. Rev. Clin. Lab. Sci. 2004 41 : 189 231.
9. Miles D Papazisis K. Rationale for the clinical development of STn-KLH (Theratope) and anti-MUC-1 vaccines in breast cancer. Clin. Breast Cancer 2003 3 : S134 8.
10. Ogawa Y Ishikawa T Ikeda K et al. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer. Clin. Cancer Res. 2000 6 : 4069 72.